Mission Bio appoints new chief medical officer

By The Science Advisory Board staff writers

April 7, 2022 -- Life sciences company Mission Bio has announced the appointment of Dr. Todd Druley, PhD, as chief medical officer (CMO), a newly created role at Mission Bio.

Druley brings to the role his vast experience in molecular diagnostics and building clinical programs, the company said in a press release. Prior to joining Mission Bio, Druley held CMO roles at Angle Biosciences and ArcherDX. He is also currently a scientific advisor for RhoDx.

Since 2016, he has also worked with Mission Bio's Tapestry Platform, the company's multiomics platform that can analyze DNA and protein simultaneously from the same sample at single-cell resolution.

Mission Bio builds on Tapestri Platform
Mission Bio has added new features to its Tapestri Platform aimed at supporting research in solid tumors.
Mission Bio announces its 1st single-cell Tapestri Center of Excellence
Mission Bio has announced its first Center of Excellence, located at Memorial Sloan Kettering Cancer Center (MSK). As the first single-cell Tapestri Center...
Researchers identify BTK inhibitor-resistant clones with Mission Bio
Mission Bio, in conjunction with researchers at Memorial Sloan Kettering Cancer Center and the University of Miami, has published new findings showing...
Mission Bio transfers 1st Tapestri GMP-ready CGT assay
Mission Bio has completed the first tech transfer of a clinical trial-, good manufacturing practices (GMP)-ready cell and gene therapy (CGT) assay from...

Copyright © 2022 scienceboard.net

Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter